Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Breast Cancer

Get Email Updates

Resource Centers

Related Checklists

Breast Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

Malarial Drug Shows ‘Hopeful’ Promise in Preventing Breast Cancer

By Lynette Summerill HERWriter
 
Rate This
Malarial Drug Shows ‘Hopeful’ Promise in Preventing Breast Cancer 3 5 15
malarial drug is promising for potentially preventing breast cancer
Nelson Marques/PhotoSpin

What does the parasitic infection, malaria, and breast cancer have in common? It looks increasingly likely that these two potentially fatal conditions can be prevented when treated with the same drug.

Researchers at George Mason University, near Washington DC, are conducting a clinical trial to see if a widely-prescribed drug used to prevent and treat malaria, called chloroquine (pronounced klor' oh kwin), will do the same for ductal carcinoma in situ, or DCIS, the most common type of pre-invasive breast cancer.

The goal is to find a short-term oral treatment that prevents breast cancer by killing the precursor cells that initiate breast cancer development, said Lance Liotta, co-director of Mason’s Center for Applied Proteomics and Molecular Medicine (CAPMM). “And it’s looking hopeful.”

The clinical trial, dubbed the Preventing Invasive Neoplasia with Chloroquine (PINC), is one of three ongoing breast cancer research projects at CAPMM that’s showing promise.

Mason University researchers say it’s still too early to know if the malaria treatment will pan out as a preventative fix for breast cancer, but CAPMM Assistant Research Professor Virginia Espina says there could come a day when chloroquine is taken by women worldwide to do just that.

DCIS shows up as white spots in the MRI of a breast. Those white spots are calcification that may mark the milk ducts where DCIS cells are growing, said Espina.

“Not all DCIS becomes cancer, but all breast cancer goes through the DCIS stage” she said.

Espina said that the PINC clinical trial is open to women diagnosed with DCIS after a biopsy, adding that the study doesn’t interfere with standard medical treatment.

Mason University researchers are working with Kirsten Edmiston, a breast surgeon at Inova Fairfax Hospital in northern Virginia who recruits the patients and clinically directs the trial .

Add a Comment1 Comments

EmpowHER Guest
Anonymous

Study not hopeful. I took the malaria pills and there is no difference.

December 26, 2012 - 9:30pm
Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1881 Health

Changed

776 Lives

Saved

644 Lives
5 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Have you been tested for BRCA gene mutation?:
View Results